S. Ersek Thoracic & Cardiovasc Surgery Center, Istanbul
Erectile dysfunction may represent generalized vascular dysfunction
Published in Biotech Law Weekly, April 28th, 2006
According to recent research from Turkey, "We hypothesize that generalized vascular dysfunction may be the underlying cause in patients with erectile dysfunction (ED) without atherosclerosis and its major risk factors."
"In all, 30 outpatients with ED and 25 healthy volunteers as a control group were enrolled for this study," wrote N. Uslu and colleagues at Siyami Ersek Thoracic & Cardiovascular Surgery Center in Istanbul. "Aortic stiffness was calculated from data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-04-28)
More Articles from Biotech Law Weekly
- Business Update
AMA Insurance to offer Cignature Rx Medicare drug plan to retired physicians - Cardium Therapeutics, Inc.
Cardium announces patent wins over Boston Scientific and Arch Development Corporation - Drug Importation
Permanent court order against Canada Care Drugs halts illegal importation of prescription drugs - EpiCept Corporation
EpiCept settles Maxim securities litigation - HemoCue, AB
HemoCue decides to enforce decision in patent infringement suit against EKF - Inex Pharmaceuticals Corp.
INEX receives "statement of claim" on gene therapy technology from Protiva Biotherapeutics - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
